Cardiac remodeling and exercise tolerance in small for gestational age: a follow-up cohort study from preadolescence into adolescence
Long-term cardiac effects in adolescents born small for gestational age
Being born small for gestational age (SGA) affects 7%–10% of newborns and is associated with increased cardiovascular risk and reduced exercise capacity in adulthood with unclear underlying mechanisms.
Cardiac remodeling and dysfunction occur in fetuses and children born SGA, but it is uncertain whether and how these changes persist into adolescence.
The aim of the study was to assess resting cardiovascular morphology and function together with exercise tolerance in adolescents born SGA.
Methods and follow-up approach
A perinatal cohort of 30 adolescents born SGA (defined as birth weight below the 10th centile) and 28 normal birth weight controls in a tertiary university hospital in Spain was included.
Participants were followed from preadolescence (age 7–12 years) into adolescence (age 12–17 years) with echocardiography and incremental cardiopulmonary exercise test (CPET).
Key findings in cardiac function and exercise
Although signs of cardiac remodeling and dysfunction were evident in SGA preadolescents, no significant differences in left ventricular dimensions and deformation could be demonstrated in SGA adolescents.
During the follow-up period, the SGA cohort had a significantly higher increase in left ventricular (LV) base-to-apex length, resulting in different change of LV sphericity.
Significant differences could be observed in SGA during exercise with reduced oxygen uptake, expired carbon dioxide, and peak expiratory flow rate.
Conclusion on cardiovascular evolution in SGA teens
Changes in cardiac shape and function, described in children born SGA, seem to be ameliorated in adolescence related to compensatory growth as compared to healthy controls.
However, SGA adolescents had markedly reduced exercise tolerance.
Authors
Rommy H. Novoa, Dora Fabijanovic, Kilian Vellvé, Filip Loncaric, Mérida Rodríguez-López, Álvaro Sepúlveda-Martínez, Sebastian I. Sarvari, Brenda Valenzuela-Alcaraz, Francesca Crovetto, Rosa Faner, Alvar Agustí, Marta Sitges, Maja Cikes, Gabriel Bernardino, Isabel Blanco, Bart Bijnens, Fàtima Crispi.
Read more details at
Fecha de publicación
Published: 18 November 2025
Categorías asociadas al artículo
Noticias relacionadas

A Pilot Study on Proteomic Predictors of Mortality in Stable COPD
Proteomic Predictors of Mortality in Stable COPD is the objective of this pilot study. It searchs to identify proteomic markers and specific multiprotein signatures that could be useful in predicting long-term mortality

Fractional exhaled nitric oxide in a respiratory healthy general population through the lifespan
Discover the normal ranges of fractional exhaled nitric oxide (FeNO) across different age groups in a respiratory healthy population. Based on 2,251 participants, this study identifies factors like age, body height, and eosinophil counts that influence FeNO levels.

Riesgo CV en el Paciente con EPOC: una visión multidisciplinar
Participa en «Riesgo Cardiovascular en el Paciente con EPOC» de la Universidad de Barcelona. Modalidad presencial y online. ¡Inscríbete ahora!

Lung-function trajectories: relevance and implementation in clinical practice
Lung-function development can be altered by several host and environmental factors during the life course. As a result, a range of lung-function trajectories exist in the population.

COPD and multimorbidity: recognising and addressing a syndemic occurrence
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.

Gold 2023: Highlights for primary care
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
Imagen desarrollada con ChatGPT y Canva